Our LAGEVRIO (molnupiravir) process chemistry team has been awarded the EPA Green Chemistry Challenge Award 2022 for developing a greener synthetic pathway to make the anti-covid19 drug molnupiravir.
Chemists shorten the synthesis of molnupiravir to prepare for scale-up: The antiviral drug candidate is in advanced clinical trials for fighting SARS-CoV-2 infection - C&EN, 2021
Scientists made an HIV drug using nothing but enzymes - C&EN, 2019
I have accepted a senior scientist position at Merck - 2017
Dartmouth researchers take aim at a deadly infection. - Vermont’s NPR, 2015
Our work “Structure-based design of combinatorial mutagenesis libraries” is selected for best poster presentation (talk given by Dr. Chris Bailey-Kellogg) - PEGS, 2014
Deeptak Verma named Distinguished Dissertation Award winner. - UNC Charlotte, 2013
Dynamical properties in antibiotic resistance enzyme investigated. - Science Daily, 2013
Best poster award winner in the Molecular Engineering and Design category at the 4th annual CBES Graduate Student Poster Competition. - UNC Charlotte, 2012
Dr. Chris Bailey-Kellogg (postdoc advisor)
Dr. Dennis Livesay (grad advisor)
Dr. Pradeep Naik (undergrad advisor)
Copyright (c) 2023 - Deeptak Verma